Hye-Kyung Kim
Fortune : 41 639 $ au 31/03/2026
Fortune : 41 639 $ au 31/03/2026
Hye-Kyung Kim is currently the Chief Executive Officer at Bridget Lifesciences Corp.
since 2003.
Ms. Kim is also the Vice Chairman & Head-Management at ENZYCHEM LIFESCIENCES Corp.
since 2012.
Additionally, Ms. Kim holds the position of Vice Chairman at Konex Association since 2014.
The education history includes an undergraduate degree from Ewha Womans University and a graduate degree from Korea National Open University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/07/2026 | 63 810 ( 0,08 % ) | 41 639 $ | 31/03/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Directeur/Membre du Conseil | 01/07/2012 |
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | 01/01/2003 |
Konex Association | Directeur/Membre du Conseil | 01/01/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Ewha Womans University
Ewha Womans University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENZYCHEM LIFESCIENCES Corp.
ENZYCHEM LIFESCIENCES Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Korea National Open University
Korea National Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Konex Association |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national